We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Plans Studies Of On-The-Market Medications

Law360 (September 25, 2006, 12:00 AM EDT) -- The Food & Drug Administration has ordered a first round of studies to address the safety of medicines already on the market. Attention deficit hyperactivity disorder, osteoporosis and contraceptive medications will be the first to face scrutiny.

Under pressure since the 2004 withdrawal of Merck & Co.’s painkiller Vioxx, the FDA has asked health insurers, such as Kaiser Permanente, to collaborate on the studies.

One of the first studies will focus on ADHD medication. The study will seek to determine whether the stimulants that are the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.